After rollout under emergency authorisation, manufacturers of covid-19 vaccines now have their sights on regulatory approval. But what’s the rush, asks Peter Doshi, and is just six months of data from now unblinded trials acceptable?http://ow.ly/at2D50F2Mqn
-
-
Inquiring minds also wonder about this.https://twitter.com/StephanEducTech/status/1398021430969778180 …
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
Show additional replies, including those that may contain offensive content
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.